Assignee
CAMBRIDGE NEUROSCIENCE INC
US·39 granted patents·676 citations·filing 1992–2000
Top patents by PatentIndex Score
39 records- 0195US6087346ASigma receptor ligands and the use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Jul 11, 2000·87 cites·17 claims
- 0292US5298657APreparation of substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1992·Granted Mar 29, 1994·40 cites·23 claims
- 0391US5681568ADevice for delivery of substances and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Oct 28, 1997·120 cites·20 claims
- 0491US5403861ASubstituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockersCAMBRIDGE NEUROSCIENCE INC·Filed 1992·Granted Apr 4, 1995·67 cites·37 claims
- 0582US5489709APreparation of substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Feb 6, 1996·16 cites·2 claims
- 0679US6087323AUse of neuregulins as modulators of cellular communicationCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Jul 11, 2000·42 cites·20 claims
- 0778US6787569B1Therapeutic guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 2000·Granted Sep 7, 2004·8 cites·7 claims
- 0874US5847006ATherapeutic guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Dec 8, 1998·15 cites·27 claims
- 0974US5686495ASubstituted hydrazinedicarboximidamides and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 11, 1997·21 cites·32 claims
- 1071US5876973AMethod for making antibodies which specifically bind to glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Mar 2, 1999·28 cites·1 claims
- 1169US6025355APharmaceutically active compounds and methods of useCAMBRIDGE NEUROSCIENCE INC·Filed 1997·Granted Feb 15, 2000·10 cites·40 claims
- 1269US5637623ASubstituted adamantyl guanidines and methods of use there ofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jun 10, 1997·17 cites·3 claims
- 1367US5837737AHydrazinedicarboximidamide compounds and pharmaceutical composition comprising sameCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 17, 1998·15 cites·22 claims
- 1464US5672608AAcenaphthyl substituted guanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1994·Granted Sep 30, 1997·8 cites·21 claims
- 1564US5438130AFucosylated guanosine disulfates as excitatory amino acid antagonistsCAMBRIDGE NEUROSCIENCE INC·Filed 1993·Granted Aug 1, 1995·18 cites·38 claims
- 1663US6147190AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 14, 2000·11 cites·22 claims
- 1762US5652269ASubstituted hydrazinecarboximidamides and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jul 29, 1997·9 cites·16 claims
- 1861US5854220AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Dec 29, 1998·9 cites·3 claims
- 1961US5741661ASubstituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockersCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Apr 21, 1998·22 cites·58 claims
- 2060US5614630AAcenaphthyl substituted guanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Mar 25, 1997·10 cites·38 claims
- 2158US6156741ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Dec 5, 2000·10 cites·52 claims
- 2258US5622968AAcenaphthyl substituted guanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Apr 22, 1997·9 cites·28 claims
- 2354US6147063ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 14, 2000·10 cites·42 claims
- 2453US6013675ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jan 11, 2000·8 cites·9 claims
- 2553US5670519AAcenaphthyl-substituted guanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Sep 23, 1997·7 cites·49 claims
- 2651US5681861AAminoguanidines and methods of use of sameCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Oct 28, 1997·6 cites·12 claims
- 2751US5677348ASubstituted aminoguanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Oct 14, 1997·6 cites·17 claims
- 2850US5955507ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Sep 21, 1999·6 cites·18 claims
- 2949US6242198B1Methods of treatment of eye trauma and disordersCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Jun 5, 2001·8 cites·11 claims
- 3048US5922772ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jul 13, 1999·5 cites·6 claims
- 3147US6143791ATherapeutic guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 7, 2000·12 cites·12 claims
- 3246US6153604ATherapeutic substituted guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 28, 2000·5 cites·47 claims
- 3343US6174924B1Therapeutic guanidinesCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jan 16, 2001·4 cites·7 claims
- 3439US6774263B1Pharmaceutically active compound and methods of useCAMBRIDGE NEUROSCIENCE INC·Filed 1998·Granted Aug 10, 2004·1 cites·8 claims
- 3539US6194377B1Methods for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Feb 27, 2001·1 cites·22 claims
- 3637US6071969ASubstituted aminoguanidines and methods of use thereofCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Jun 6, 2000·1 cites·45 claims
- 3736US6232061B1Homology cloningCAMBRIDGE NEUROSCIENCE INC·Filed 1992·Granted May 15, 2001·3 cites·39 claims
- 3835US6204241B1Method for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Mar 20, 2001·1 cites·21 claims
- 3930US6756389B2Pharmaceutically active compounds and methods of useCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Jun 29, 2004·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when CAMBRIDGE NEUROSCIENCE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →